NeoPharm (Korea) Price on December 19, 2024
| 092730 Stock | KRW 11,980 20.00 0.17% |
If you're considering investing in NeoPharm Stock, it is important to understand the factors that can impact its price. As of today, the current price of NeoPharm stands at 11,980, as last reported on the 20th of December, with the highest price reaching 12,080 and the lowest price hitting 11,650 during the day. At this point, NeoPharm is very steady. NeoPharm LTD has Sharpe Ratio of 0.04, which conveys that the firm had a 0.04% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for NeoPharm, which you can use to evaluate the volatility of the firm. Please verify NeoPharm's Downside Deviation of 2.74, risk adjusted performance of 0.0291, and Mean Deviation of 2.1 to check out if the risk estimate we provide is consistent with the expected return of 0.11%.
NeoPharm Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
NeoPharm |
Sharpe Ratio = 0.04
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | 092730 | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.83 actual daily | 25 75% of assets are more volatile |
Expected Return
| 0.11 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average NeoPharm is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NeoPharm by adding it to a well-diversified portfolio.
NeoPharm Valuation on December 19, 2024
It is possible to determine the worth of NeoPharm on a given historical date. On December 19, 2024 NeoPharm was worth 11780.0 at the beginning of the trading date compared to the closed value of 11980.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of NeoPharm stock. Still, in general, we apply an absolute valuation method to find NeoPharm's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of NeoPharm where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against NeoPharm's related companies.
| Open | High | Low | Close | Volume | |
| 12,000 | 12,030 | 11,790 | 12,000 | 40,493 | |
12/19/2024 | 11,780 | 12,080 | 11,650 | 11,980 | 45,149 |
| Backtest NeoPharm | | | NeoPharm History | | | NeoPharm Valuation | Previous |
NeoPharm Trading Date Momentum on December 19, 2024
| On December 19 2024 NeoPharm LTD was traded for 11,980 at the closing time. The highest price during the trading period was 12,080 and the lowest recorded bid was listed for 11,650 . The volume for the day was 45.1 K. This history from December 19, 2024 did not cause price change. The trading delta at closing time to the current price is 1.67% . |
NeoPharm LTD Fundamentals Correlations and Trends
By evaluating NeoPharm's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among NeoPharm's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. NeoPharm financial account trend analysis is a perfect complement when working with valuation or volatility modules.About NeoPharm Stock history
NeoPharm investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NeoPharm is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NeoPharm LTD will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NeoPharm stock prices may prove useful in developing a viable investing in NeoPharm
,Ltd. manufactures and sells skin care products in Korea and internationally. ,Ltd. was founded in 2000 and is headquartered in Daejeon, South Korea. Neopharm is traded on Korean Securities Dealers Automated Quotations in South Korea.
NeoPharm Stock Technical Analysis
NeoPharm technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
NeoPharm Period Price Range
Low | December 20, 2024
| High |
0.00 | 0.00 |
NeoPharm LTD cannot be verified against its exchange. Please verify the symbol is currently traded on KOSDAQ. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
NeoPharm December 20, 2024 Market Strength
Market strength indicators help investors to evaluate how NeoPharm stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NeoPharm shares will generate the highest return on investment. By undertsting and applying NeoPharm stock market strength indicators, traders can identify NeoPharm LTD entry and exit signals to maximize returns
NeoPharm Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for NeoPharm's price direction in advance. Along with the technical and fundamental analysis of NeoPharm Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NeoPharm to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0291 | |||
| Jensen Alpha | 0.0729 | |||
| Total Risk Alpha | (0.02) | |||
| Sortino Ratio | 0.0158 | |||
| Treynor Ratio | (0.25) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for NeoPharm Stock analysis
When running NeoPharm's price analysis, check to measure NeoPharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeoPharm is operating at the current time. Most of NeoPharm's value examination focuses on studying past and present price action to predict the probability of NeoPharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeoPharm's price. Additionally, you may evaluate how the addition of NeoPharm to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |